Medable
Palo Alto, US · Delaware corporation · 11 known investors
Medable provides a cloud-based platform for clinical research that uses AI and digital tools to accelerate the development of therapies by improving the quality, reach, and efficiency of clinical trials. The platform serves pharmaceutical sponsors, contract research organizations (CROs), and clinical research sites.
Founders & leadership
ML
Michelle LongmireFounder
YA
Young A. SohnDirector
RL
Richard LimDirector
AL
Anna LongDirector
PR
Perry RobinsonExecutive Officer
DH
David HartwigDirector
TR
Timothy R. SmithExecutive Officer, Director
Investors · 11
ACVC PartnersSilicon Valley
Connectivity VenturesNew York
HealthX VenturesMadison
Informed Ventures Advisors, LlcMenlo Park
Obvious VenturesSan Francisco · $250K – $6M
PROOFArlington
Sapphire VenturesAustin · $5M – $20Mvia David Hartwig · board
Streamlined VenturesPalo Alto · $100K – $1M
TMC Venture FundHouston
GSR VenturesreportedBeijing · $2.3M – $74M
Tiger Global ManagementreportedNew York · $1M – $100M
Reported raises · per SEC filings
Form D private placements▶$304MraisedNov 2021 · 8 investors · Other Health CareRule 506(b)
▶$304MraisedNov 2021 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michelle LongmireExecutive Officer, Director
- Anna LongDirector
- David HartwigDirector
- Richard LimDirector
- Timothy R. SmithExecutive Officer, Director
- Perry RobinsonExecutive Officer
- Young A. SohnDirector
- Offering amount
- $304M
- Amount sold
- $304M
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$78MraisedApr 2021 · 9 investors · Other Health CareRule 506(b)
▶$78MraisedApr 2021 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Young A. SohnDirector
- Richard LimDirector
- Anna LongDirector
- Perry RobinsonExecutive Officer
- David HartwigDirector
- Michelle LongmireExecutive Officer, Director
- Timothy R. SmithExecutive Officer, Director
- Offering amount
- $78M
- Amount sold
- $78M
- First sale
- Apr 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$63.6MraisedNov 2020 · 7 investors · Other Health CareRule 506(b)
▶$63.6MraisedNov 2020 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michelle LongmireExecutive Officer, Director
- Timothy R. SmithExecutive Officer, Director
- Young A. SohnDirector
- Anna LongDirector
- Richard LimDirector
- David HartwigDirector
- Perry RobinsonExecutive Officer
- Offering amount
- $93.6M
- Amount sold
- $63.6M
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedOct 2020 · 1 investors · Other Health CareRule 506(b)
▶$10MraisedOct 2020 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michelle LongmireExecutive Officer, Director
- Timothy R. SmithExecutive Officer, Director
- Young A. SohnDirector
- Anna LongDirector
- Richard LimDirector
- Perry RobinsonExecutive Officer
- Offering amount
- $10M
- Amount sold
- $10M
- Minimum investment
- $1
- First sale
- Sep 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$25.7MraisedApr 2020 · 3 investors · Other Health CareRule 506(b)
▶$25.7MraisedApr 2020 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Richard LimDirector
- Michelle LongmireExecutive Officer, Director
- Timothy R. SmithExecutive Officer, Director
- Perry RobinsonExecutive Officer
- Young A. SohnDirector
- Anna LongDirector
- Offering amount
- $31.1M
- Amount sold
- $25.7M
- Minimum investment
- $1
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$16.1MraisedApr 2020 · 8 investors · Other Health CareRule 506(b)
▶$16.1MraisedApr 2020 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michelle LongmireExecutive Officer, Director
- Timothy R. SmithExecutive Officer, Director
- Young A. SohnDirector
- Offering amount
- $16.1M
- Amount sold
- $16.1M
- Minimum investment
- $1
- First sale
- Jul 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.6MraisedDec 2016 · 12 investors · Other Health CareRule 506(b)
▶$3.6MraisedDec 2016 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michelle LongmireExecutive Officer, Director
- Robert DugganDirector
- Timothy SmithDirector
- Mahkam ZanganehDirector
- Offering amount
- $8.4M
- Amount sold
- $3.6M
- Minimum investment
- $1
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Medable Raises $304M Series D to | SignalBasetrysignalbase.com · 2026
- Decentralized trial tech firm Medable raises another $300mbioxconomy.com · 2021
- Medable reaches $2.1B valuation as Tiger, Blackstone, GSR pump new capital into clinical trials management company | TechCrunchtechcrunch.com · 2021
- Medable Secures $304 Million in Funding at $2.1 Billion Valuation; New Round Co-Led by Blackstone Growth, GSR Ventures and Tiger Globalbusinesswire.com · 2021
- Medable Raises $91 Million To Accelerate The Shift To Decentralized Clinical Trialspulse2.com · 2020
- Medable Secures $25M Funding To Reduce Clinical Trial Timelinesnews.crunchbase.com · 2020